PolyCore Therapeutics Competitors and Similar CompaniesClear all
Sosei Heptares's competitors and similar companies include Travere Therapeutics and OTR3.
 Travere Therapeutics Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases. |  OTR3 OTR3 is a biotech company that develops therapeutic agents for skin, mucosa, and corneal complications. | ||
Founding Date | Founding Date 1990 | Founding Date 2011 | Founding Date 2005 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Tokyo, JP HQ Dublin, IE Cambridge, GB London, GB | Locations San Diego, US HQ Dublin, IE | Locations Paris, FR HQ |
Employees | Employees 387 | Employees 46293% increase | Employees 23 |
Valuation ($) | Valuation ($) 697 m | Valuation ($) 1.4 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) ¥29.6b (FY, 2025) | Revenue (est.) $490.7m (FY, 2025) | Revenue (est.) N/A |
Cost of goods | Cost of goods ¥7.3b (FY, 2025) | Cost of goods $10.3m (FY, 2025) | Cost of goods N/A |
Gross profit | Gross profit ¥24b (FY, 2025) | Gross profit $480.4m (FY, 2025) | Gross profit N/A |
Net income | Net income (¥12.5b) (FY, 2025) | Net income ($25.5m) (FY, 2025) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised $ 65m | Total funding raised $ 25m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
Travere Therapeutics
HQ
San Diego, US
Employees
462
Travere Therapeutics is a biopharmaceutical company that focuses on the development, acquisition, and commercialization of therapies for the treatment of serious or rare diseases.
View companyOTR3
HQ
Paris, FR
Employees
23
OTR3 is a biotech company that develops therapeutic agents for skin, mucosa, and corneal complications.
View company